FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Researchers tout early results for bird flu vaccine

Tools

Chinese health officials are touting preclinical data for a new bird flu vaccine. A 10 microgram dose of the vaccine, which includes four antigens, created a 78.3 percent response in antibodies needed to protect people from bird flu. Beijing Sinovac Biotech Co says it is readying a second round of tests, well on the way to completing the three rounds health officials rely on for drug approvals in China. About a dozen companies are working on flu vaccines.

- read the report on the vaccine from the People's Daily

PLUS: Federal officials at the CDC have unveiled a new avian flu test that cuts the time it takes to analyze bird flu cases from a week to less than a day. Called FluChip, it incorporates genetic material on a microchip. The new test allows for mass testing and much quicker response times in dealing with flu outbreaks among people and animals. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about flu vaccine   CDC   Regulators   Avian flu vaccine